Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rulesnews2021-10-08T14:27:25+00:00October 8th, 2021|Fierce Pharma|
Amgen’s latest Lumakras data in KRAS cancer underscore the bumpy road for combo strategy: analystnews2021-10-08T14:05:11+00:00October 8th, 2021|Fierce Pharma|
Neurocrine raises a new monument to mental health in pandemic resilience campaignnews2021-10-08T10:31:14+00:00October 8th, 2021|Fierce Pharma|
Fierce Pharma Asia—Takeda’s narcolepsy trial problem, gene therapy pact; human error in Moderna’s COVID vaccinenews2021-10-08T10:06:30+00:00October 8th, 2021|Fierce Pharma|
New FDA chief set to be nominated by Biden, 9 months into his tenurenews2021-10-07T19:47:55+00:00October 7th, 2021|Fierce Pharma|
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next yearnews2021-10-07T18:14:15+00:00October 7th, 2021|Fierce Pharma|
White House spat with Moderna intensifies with pressure building to donate more COVID vaccines: reportnews2021-10-07T17:09:09+00:00October 7th, 2021|Fierce Pharma|
Pfizer requests FDA nod for COVID-19 shot in kids 5 to 11, but convincing parents might be a tough sellnews2021-10-07T15:27:10+00:00October 7th, 2021|Fierce Pharma|
How can pharma grab attention in the streaming TV era? Visual storytelling, says Evoke KYNE creative head Brettnews2021-10-07T14:42:23+00:00October 7th, 2021|Fierce Pharma|
AbbVie touts more Rinvoq data in inflammatory spinal arthritis as it awaits key FDA decisionsnews2021-10-07T14:37:30+00:00October 7th, 2021|Fierce Pharma|
